Short-term esmolol attenuates remodeling of the thoracic aorta in hypertensive rats by decreasing concentrations of ADMA down-regulated by oxidative stress
Standard
Short-term esmolol attenuates remodeling of the thoracic aorta in hypertensive rats by decreasing concentrations of ADMA down-regulated by oxidative stress. / Quintana-Villamandos, Begoña; González, María Carmen; Delgado-Martos, María Jesús; Condezo-Hoyos, Luis; Böger, Rainer H; Lüneburg, Nicole; Pazó-Sayós, Laia; Gutiérrez-Arzapalo, Perla Yareli; Delgado-Baeza, Emilio.
In: EUR J PHARMACOL, Vol. 791, 15.11.2016, p. 502-509.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Short-term esmolol attenuates remodeling of the thoracic aorta in hypertensive rats by decreasing concentrations of ADMA down-regulated by oxidative stress
AU - Quintana-Villamandos, Begoña
AU - González, María Carmen
AU - Delgado-Martos, María Jesús
AU - Condezo-Hoyos, Luis
AU - Böger, Rainer H
AU - Lüneburg, Nicole
AU - Pazó-Sayós, Laia
AU - Gutiérrez-Arzapalo, Perla Yareli
AU - Delgado-Baeza, Emilio
N1 - Copyright © 2016 Elsevier B.V. All rights reserved.
PY - 2016/11/15
Y1 - 2016/11/15
N2 - Esmolol produces early regression of left ventricular hypertrophy and improves coronary artery remodeling, although the impact of short-term treatment with this beta-blocker on remodeling in large arteries has not yet been studied. We hypothesized that even a short (48h) course of esmolol might alter remodeling of the aorta in the spontaneously hypertensive rat (SHR). Fourteen-month-old male SHRs were treated intravenously with vehicle (SHR, n=8) or esmolol (SHR-E, n=8) (300μg/kg/min). Age-matched, vehicle-treated male Wistar-Kyoto rats (WKY, n=8) served as controls. After 48h, we studied the structure, volume density of elastic fibers, and passive mechanical properties of the aorta. Determination of asymmetrical dimethylarginine concentrations and total protein carbonyls in the aorta were analyzed. Esmolol significantly attenuated abnormal aortic wall thickness, cross-sectional area, wall-to-lumen ratio, volume density of elastic fibers, and wall stiffness. The protective effect of esmolol could be related to a decrease in asymmetrical dimethylarginine levels after down-regulation by oxidative stress. These findings could play a key role in the selection of antihypertensive therapy in patients with hypertension and aortic remodeling.
AB - Esmolol produces early regression of left ventricular hypertrophy and improves coronary artery remodeling, although the impact of short-term treatment with this beta-blocker on remodeling in large arteries has not yet been studied. We hypothesized that even a short (48h) course of esmolol might alter remodeling of the aorta in the spontaneously hypertensive rat (SHR). Fourteen-month-old male SHRs were treated intravenously with vehicle (SHR, n=8) or esmolol (SHR-E, n=8) (300μg/kg/min). Age-matched, vehicle-treated male Wistar-Kyoto rats (WKY, n=8) served as controls. After 48h, we studied the structure, volume density of elastic fibers, and passive mechanical properties of the aorta. Determination of asymmetrical dimethylarginine concentrations and total protein carbonyls in the aorta were analyzed. Esmolol significantly attenuated abnormal aortic wall thickness, cross-sectional area, wall-to-lumen ratio, volume density of elastic fibers, and wall stiffness. The protective effect of esmolol could be related to a decrease in asymmetrical dimethylarginine levels after down-regulation by oxidative stress. These findings could play a key role in the selection of antihypertensive therapy in patients with hypertension and aortic remodeling.
KW - Animals
KW - Aorta, Thoracic/drug effects
KW - Arginine/analogs & derivatives
KW - Blood Pressure/drug effects
KW - Down-Regulation/drug effects
KW - Heart Rate/drug effects
KW - Male
KW - Oxidative Stress/drug effects
KW - Propanolamines/pharmacology
KW - Protein Carbonylation/drug effects
KW - Rats
KW - Rats, Inbred SHR
KW - Tensile Strength/drug effects
KW - Vascular Remodeling/drug effects
U2 - 10.1016/j.ejphar.2016.09.020
DO - 10.1016/j.ejphar.2016.09.020
M3 - SCORING: Journal article
C2 - 27639298
VL - 791
SP - 502
EP - 509
JO - EUR J PHARMACOL
JF - EUR J PHARMACOL
SN - 0014-2999
ER -